2m 2m 2m 2m 2m 2m 2m
Abbott Laborator (ABT)
NYSE
$116.52-$0.12 (-0.10%)
Price as of Aug 21, 2026 7:59 PM EDT- $201.8BMarket Cap
- -10.00%1-Year Change
- Medical DevicesIndustry
Abbott Laborator (ABT)
$116.52-$0.12 (-0.10%)
ABT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $116.64 | ||
Change | +$2.50 (+2.19%) | ||
Open | $114.02 | ||
High | $116.66 | ||
Low | $113.45 | ||
Previous Close | $114.14 | ||
Volume | 10,931,303 | ||
30-Day Average Volume | 8,760,474 | ||
1-Week Change | 4.84% | ||
1-Month Change | 17.03% | ||
1-Year Change | -10.00% | ||
3-Year Change | 19.53% | ||
5-Year Change | 1.77% | ||
Fundamentals | |||
Shares Outstanding | 1.7B | ||
Total Assets | $109.2B | ||
Market Cap | $201.8B | ||
Enterprise Value | $229.3B | ||
Period: QTR TTM FY | |||
Revenue | $12.6B | ||
Net Income | $928.0M | ||
Free Cash Flow | $2.0B | ||
EBIT | $1.8B | ||
EBITDA | $2.5B | ||
Net Working Capital | $6.7B | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 92 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 4 | ||
P/E | 220 | ||
PEG | -17 | ||
Price/Free Cash Flow | 101 | ||
Price/Operating Cash Flow | 81 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.16% | ||
Trailing Annual Dividend Yield | 2.13% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield